DRUG NAME: Cetuximab
*Colorectal cancer Lung cancer, non -small cell3 *Head and neck cancer *Health Canada approved indication . Cetuximab BC Cancer Agency Cancer Drug Manual ...
Tags:
Lungs, Canada, Cancer, Cancer lung cancer
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
BC CANCER HAZARDOUS DRUG LIST
www.bccancer.bc.caBC CANCER HAZARDOUS DRUG LIST (Refer to: Pharmacy Directive VI-80 Hazardous Drug List) The BC Cancer Hazardous Drug List (BC Cancer HD List) is comprised of:
British Columbia Cancer Agency POLICY
www.bccancer.bc.caBritish Columbia Cancer Agency ¦ POLICY Title: PREVENTION AND MANAGEMENT OF EXTRAVASATION OF CHEMOTHERAPY Number: III-20 Effective Date: Provincial Systemic Program September 1,1997
Policy, Management, Prevention, Agency, Columbia, British, Cancer, British columbia cancer agency policy, British columbia cancer agency, 166 policy
Safe Handling of Hazardous Drugs - BC Cancer
www.bccancer.bc.caA.1 Potential Hazards of Handling Hazardous Drugs..... 1 A.2 Hazardous Drug List.....
“Magic” mouthwash explained - BC Cancer
www.bccancer.bc.caFAMILY PRACTICE ONCOLOGY NETWORK JOURNAL / FALL 2014 3 “Magic” mouthwash explained By Dr. Allan Hovan, Provincial Professional Practice Leader,
Guidelines for Management of CID - BC Cancer
www.bccancer.bc.caDisclaimer Both the format and content of the guidelines will change as they are reviewed and revised on a periodic basis. Any physician using these guidelines to provide
Oncology Nutrition High Protein High Energy …
www.bccancer.bc.caHigh Protein High Energy Food Choices 3 Examples of High Protein Foods • All meat (eg. beef, pork, goat, lamb) • Fish and shellfish • All poultry (eg. chicken, turkey, duck)
High, Food, Energy, Nutrition, Oncology, Protein, Oncology nutrition high protein high energy, Protein foods
Symptom Management Guidelines: ORAL …
www.bccancer.bc.caSymptom Management Guidelines: ORAL MUCOSITIS . Definition Oral Mucositis (Stomatitis): An acute inflammation and/or ulceration of the …
Guidelines, Management, Symptom, Oral, Symptom management guidelines, Oral mucositis, Mucositis
Symptom Management Guidelines: FEVER AND …
www.bccancer.bc.caSymptom Management Guidelines: FEVER AND NEUTROPENIA . Definition • Fever: A single oral temperature of ≥ 38.3° C (101° F) OR a temperature ≥ 38 ° C (100.4 ° F) which lasts more than 1h
Guidelines, Management, Fever, Symptom, Oral, Symptom management guidelines, Fever and, Fever and neutropenia, Neutropenia
Symptom Management Guidelines: XEROSTOMIA
www.bccancer.bc.caSymptom Management Guidelines: XEROSTOMIA. Definition(s) • Xerostomia: abnormal dryness in the mouth characterized by a marked decrease and/or thickening of saliva, may be
Guidelines, Management, Symptom, Symptom management guidelines, Xerostomia
Linking the BC Psychosocial Community Oncology …
www.bccancer.bc.caCarolyn Jacob - New Regional Professional Practice Leader at the Centre for the North. We welcome Carolyn Jacob, MSW, RSW to her new role at the BC
Psychosocial, Community, Linking, Oncology, Linking the bc psychosocial community oncology
Related documents
DRUG NAME: Paclitaxel - BC Cancer
www.bccancer.bc.ca*Breast cancer Lung cancer, small cell: 2 *Lung cancer, non -small cell Esophageal cancer: 2 *Ovarian cancer Bladder cancer: 2 *Kaposi’s Sarcoma Head and Neck cancer: 2: Cervical cancer: 2: Endometrial cancer: 2 *Health Canada approved indication : SPECIAL PRECAUTIONS:
DRUG NAME: Etoposide - BC Cancer
www.bccancer.bc.ca*Lung cancer, small cell Wilm’s tumour *Lung cancer, non -small cell *Lymphoma Ovarian cancer Prostate cancer ... Sandoz Canada Inc. supplies etoposide injection as 100 mg, 200 mg, 500 mg, and 1 g ready-to-use multi-dose vials in a concentration of 20 mg/mL. Benzyl alcohol is included as preservative.
DRUG NAME: Nivolumab - BC Cancer
www.bccancer.bc.ca*Liver cancer *Health Canada approved indication ... interstitial lung disease, including fatal cases, have occurred during and after nivolumab treatment. The median time to onset is 12 weeks (range: 9-22 weeks). 1. Patients may present with new or worsening cough, chest pain, and/or shortness of breath. For grade 2 pneumonitis, withhold nivolumab,
DRUG NAME: Palbociclib - BC Cancer
www.bccancer.bc.ca13. BC Cancer Breast Tumour Group. (UBRAVPALAI) BC Cancer Protocol Summary for Therapy of Advanced Breast Cancer Using Palbociclib and Aromatase Inhibitor with or without LHRH Agonist. Vancouver, British Columbia: BC Cancer; 1 September 2018. 14. Pfizer Canada Inc. IBRANCE® product monograph. Kirkland, Quebec; 5 June 2018.
PATIET EDUCATIO INFORMATION SERIES
www.thoracic.orgunique chemicals including many cancer-causing chemicals (carcinogens) similar to tobacco smoke. Current evidence is evolving as to whether inhaled marijuana is an independent risk factor for the development of lung cancer. For those with lung cancer and are on treatment, smoking tobacco increases risk of dying and decreases the
Physician, Nurse Practitioner and Physician Assistant Bios
www.northshore.orgDr. Grinblatt also serves on the Executive Committee of the Cancer and Leukemia Group B research group. He has authored numerous peer-reviewed articles related to his work in hematology Britt E. Hanson, DO, Hematology Oncologist Dr. Britt Hanson is a board-certified hematologist with expertise in lung cancer and melanoma.
Global Initiative for Chronic Disease
goldcopd.organxiety, and lung cancer. These comorbidities should be actively sought and treated appropriately when present as they can influence mortality and hospitalizations independently. DIAGNOSIS . COPD should be considered in any patient who has dyspnea, chronic cough or sputum production, and/or history of exposure to risk factors for the disease.
Global, Lungs, Initiative, Chronic, Cancer, Lung cancer, Global initiative for chronic
Solid Tumor Rules 2022 - seer.cancer.gov
seer.cancer.govLung, Head & Neck, Kidney, and Urinary. Cutaneous melanoma was updated for 2021, and Other Sites is planned to be updated for 2023 (the 2007 MPH …
Outpatient Cancer Drug Benefit Program List
www.albertahealthservices.ca“Cancer Pharmacy” means the pharmacy at the Cross Cancer Institute and the Tom Baker Cancer Centre, and other pharmacies operated by or for cancer centre as outlined in Ministerial Order #10/2009 . Subject to this Ministerial Order, Cancer Drugs may be: 1. administered directly to in-patients or out-patients of Cancer Centres, or 2. sent to: